書籍詳細

第I章 敗血症・感染性心内膜炎

P.15 掲載の参考文献

• 1) Kaplan SL:Bacteremia and septic shock. In:Textbook of pediatric infectious diseases (Feigin RD, Cherry JD, ed), 4th ed, pp807-820, WB Saunders, Philadelphia, 1998.

• 2) Members of the American college of Chest Physician/Society of Critical Care Medicine consensus conference committee:Difinitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864-874, 1992.

• 3) The ACCP/SOCM consensus conference committee:Difinitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101:1644-1655, 1992.

• 4) 堀田昌宏:新生児の腸内細菌叢と感染. 感染症学雑誌 57:405-418, 1983.

• 5) 藤井良知, 西村忠史:小児敗血症の現況 (1980-1984年) 第1報 本邦48施設におけるアンケート調査成績. 年度, 年齢別頻度ならびに原因菌について. 感染症学雑誌 60:7-13, 1986.

• 6) 藤井良知, 西村忠史:小児敗血症の現況 (1980-1984年) 第2報 本邦48施設におけるアンケート調査成績. 予後, 基底疾患ならびに合併症について. 感染症学雑誌 60:167-175, 1986.

• 7) 佐藤達也, 和田靖之, 岡崎 実ほか:過去20年間に経験した小児敗血症の臨床的検討第1報 原因菌の解析. 感染症学雑誌 70:775-783, 1996.

• 8) 佐藤吉壮:敗血症 (新生児を含む). 小児科臨床 52:309-314, 1999.

• 9) Starke JR:Infective endocarditis. In:Textbook of pediatric infectious diseases (Feigin RD, Cherry JD, ed), 4th ed, pp315-338, WB Saunders, Philadelphia, 1998.

• 10) Bernstein D:Infective endocarditis. In:Nelson textbook of pediatrics (Behrman RE, Kliegman RM, Jenson HB, ed), 16th ed, pp1425-1428, WB Saunders, Philadelphia, 2000.

• 11) 竹田周吾, 山下直哉:心内膜炎・心筋炎. 小児科臨床 52:302-308, 1999.

• 12) 岩田 敏, 山下行雄, 岩井英人ほか:メチシリン耐性黄色ブドウ球菌による感染性心内膜炎の幼児例-治療経過と検出菌の薬剤感受性の解析-. 感染症学雑誌 61:178-188, 1987.

• 13) Dajani AS, Taubert KA, Wilson W, et al:Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA 277:1794, 1997.
  pubmed

第II章 呼吸器系細菌感染症

P.37 掲載の参考文献

• 1) Rowe RT, Stone RT:Streptococcal pharyngitis in children. Difficulties in diagnosis on clinical grounds alone. Clin Pediatri 16:933-935, 1977.

• 2) Bisno AL:Acute pharyngitis:etiolory and diagnosis. Pediatrics 97:S949-S954, 1996.

• 3) 上原すゞ子, 寺嶋 周, 野本泰正ほか:気道感染症細菌感染. 小児科診療 39:20-32, 1976.

• 4) 藤川 敏:A群レンサ球菌迅速診断法の比較. 小児科 38:339-342, 1997.

• 5) 目黒英典:A群レンサ球菌迅速診断キットの有用性. 小児科臨床 50:593-597, 1997.
  Medical*Online

• 6) Gerber MA, Spadaccini LJ, Wright LL, et al:Twice-daily penicillin in the treatment of streptococcal pharyngitis. AJDC 139:1145-1148, 1985.
  pubmed

• 7) Pichichero ME:Cepharosporins are superior to penicillin for treatment of streptococcal tonsillopharyngitis:is the difference worth it? Pediatr Infect Dis J 12:268-274, 1993.

• 8) Shulman ST:Evaluation of penicillins, cepharosporins, and macrolides for therapy of streptococcal pharyngitis. Pediatrics 97:S955-S959, 1996.

• 9) 武田修明, 河村一郎, 田中陸男ほか:最近23年間のA群溶連菌感染症と分離株のT血清型別について. 小児感染免疫 11:363-368, 1999.

• 10) 市村恵一, 田中利善, 田久保正道ほか:いわゆる「グループ」の概念の再整理. 日気食会報 40:276-283, 1989.

• 11) Orenstein DM:Acute inflammatory upper airway obstruction. In:Nelson Textbook of Pediatrics (Behrman RE, et al, ed), 15th ed, pp1201-1205, WB Saunder, Philadelphia, Tokyo, 1996.

• 12) Mayo-Smith MF, Spinale JW, Donskey CJ, et al:Acute epiglottitis. An 18-year experience in Rhode island. Chest 108:1640-1647, 1995.
  pubmed

• 13) Cressman WR, Myer III CM:Diagnosis and management of croup and epiglottitis. Ped Clin North Am 41:265-276, 1994.

• 14) Donnelly BW, McMillan JA, Weiner LB:Bacterial tracheitis:Report of eight new cases and review. Rev Infect Dis 12:729-735, 1990.
  pubmed

• 15) 鈴木伸代, 黒崎知道, 玉井和人ほか:細菌によるグループ症候群 -H.influenzae type bによる急性喉頭蓋炎とS.aureus による細菌性気管炎. 小児感染免疫 9:186-187, 1997.

• 16) 中村 明, 石川信泰, 鈴木 宏ほか:12年間に分離した小児呼吸器感染症由来インフルエンザ菌の検討. 日児誌 99:1234-1241, 1995.

• 17) Doern GV, Brueggemann AB, Pierce G, et al:Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of β-lactamase-positive strains resistant to amoxicillin-clavulanate:Results of a national multicenter surveillance study Antimicrob Agents Chemother 41:292-297, 1997.

• 18) Ishiwada N, Kuroki H, Ishikawa N, et al:Characteristics of β-lactamase producing and amoxicillin-clavulanate resistant strains of Haemophilus influenzae isolated from pediatric patient. J Infect Chemother 4:112-115, 1998.

• 19) Stern RC:Chronic bronchitis. In:Nelson Textbook of Pediatrics, (Behrman RE et al, ed), 15th ed pp1210-1211, WB Saunder, Philadelphia, Tokyo, 1996.

• 20) 上原すゞ子:I.慢性気管支炎. 新しい考え方による小児気道疾患の日常診療 (久保政次編), pp124-133, 南山堂, 1981.

• 21) Gwaltney, Jr JM:Acute bronchitis. In:Principals and practice of Infectious Diseases (Mandel GL, et al, ed), 4th ed, pp606-608, Churchill Livingstone, New York, 1995.

• 22) 黒崎知道:呼吸器感染症-気管支炎・肺炎の原因菌. New Mook 小児科4 小児の感染症と化学療法-最近の話題 (砂川慶介編), pp32-39, 金原出版, 1993.

• 23) 黒木春郎, 黒崎知道:呼吸器感染症におけるインフルエンザ菌の役割 (小児). 化学療法の領域 14:79-84, 1998.

• 24) Uehara S, Terashima I, Nakamura A, et al:The role of Haemophilus influenzae in lower respiratory infections in childhood. Acta Paediatr Jpn 27:94-101, 1985.

• 25) 久保政次:痰の組成ととり方, 各種疾患の細胞像. 新しい考え方による小児気道疾患の日常診療 (久保政次編), pp12-24, 南山堂, 1981.

• 26) 上原すゞ子:小児呼吸器疾患の診断法, 新小児医学大系9A(小林登他編), pp240-261, 中山書店, 1982.

• 27) 黒崎知道, 上原すゞ子:小児呼吸器感染症の診断と治療 I. 細菌 日本小児呼吸器疾患学会誌 5(2):68-73, 1994.

• 28) Schroeckenstein DC, Busse WW:Viral "bronchitis" in childhood:relationship to asthma and obstructive lung disease. Semin Respir Infect 3:40-48, 1988.
  pubmed

• 29) Moffet HL:Pneumonia syndromes. in Pediatric Infectious Disease-A problem oriented approach. 3rd ed, pp146-196, Lippincott, 1989.

• 30) 上原すゞ子:呼吸器細菌感染症. 小児科学(白木和夫, 前川喜平編). pp607-614, 医学書院, 東京, 1997.

• 31) 黒崎知道, 太田文夫, 玉井和人ほか:小児肺炎の実態と治療に関する検討. 日児誌 101:323, 1997.

• 32) Turner RB, Lande AE, Chase P, et al:Pneumonia in pediatric outpatient:cause and clinical manifestations. J Pediatr 111:194-200, 1987.
  pubmed

• 33) 黒崎知道, 鳥羽 剛, 斉藤能厚ほか:最近の小児肺炎. 小児科 29:1361-1369, 1988.

• 34) 石和田稔彦, 黒崎知道, 鳥羽 剛ほか:小児肺炎の現況-第2報-炎症反応, 臨床症状, 理学的所見からの検討. 感染症誌 69:284-290, 1995.

• 35) Swischuk LE, Hayden CK Jr:Viral vs. bacterial pulmonary infections in children (ls roentgenographic differentiation possible?) Pediatr Radiol 16:278-284, 1986.

• 36) Khamapirad T, Glezen WP:Clinical and radiographic assessment of acute lower respiratory tract disease in infants and children. Semin Respir Infect 2:130-144, 1987.
  pubmed

• 37) 石和田稔彦, 黒崎知道, 鳥羽 剛ほか:小児肺炎の現況-胸部X線像の検討-日児誌 98:2012-2016, 1994.

• 38) World Health Organization:Programme for the control of acute respiratory infections:technical bases for the WHO recommendations on the management of pneumonia in children at first-level health facilities. WHO/ARI/91.20

• 39) 黒崎知道, 石和田稔彦:起炎病原体別からみた小児肺炎. 日本小児呼吸器疾患学会誌 9(2):124-134, 1998.

• 40) Schreiber JR, Jacobs MR:Antibiotic-resistant pneumococci. Ped Clin North Am 42:519-537, 1995.

• 41) Bradley JS, Kaplan SL, Klugman KP, et al:Consensus:management of infections in children caused by Streptococcus pneumoniae with decreased susceptibility to penicillin. Pediatr Infect Dis J 14:1037-1041, 1995.
  pubmed

• 42) 上原すゞ子, 中村 明:小児急性呼吸器感染症の病原診断と予後-わが国における死亡例の検討-. 抗研誌 37:177-185, 1985.

• 43) 杉田麟也:小児急性中耳炎検出菌と薬剤感受性. JOHNS 13:1139-1145, 1997.

• 44) 黒崎知道, 桜井信清, 中村 明ほか:小児急性中耳炎の起因菌と薬剤感受性について. 小児科 24:917-921, 1983.

• 45) 丸山 純, 有友 宏, 稲木匠子ほか:0歳児の急性中耳炎の臨床的研究. 日耳鼻 99:402-410, 1996.

• 46) 工藤典代:急性中耳炎, 急性乳突炎. JOHNS 14:555-560, 1998.

• 47) Dowell SF, Marcy SM, Phillip WR, et al:Ottitis media-principles of judicious use of antimicrobial agents. Pediatrics 101:S155-S171, 1998.

• 48) Kaliner MA, Osguthorpe JD, Fireman P, et al:Sinusitis:Bench to bedside. Current finding, future directions. J Allergy Clin Immunol 99:S829-S848, 1997.
  pubmed

• 49) O'Brien KL, Dowell SF, Schwartz B, et al:Acute sinusitis-principles of judicious use of antimicrobial agents. Pediatrics 101:S174-S177, 1998.

• 50) 藤森 功, 菊島一仁:副鼻腔炎の細菌学. 日胸 55:S20-S25, 1996.

• 51) 間島雄一:小児の慢性副鼻腔炎. 小児科 36:1333-1340, 1995.

• 52) 杉本和夫:経口交感神経刺激剤の使用法と気道分泌物. 小児内科 25:663-667, 1993.

第III章 消化器細菌感染症

P.57 掲載の参考文献

• 1) 竹田美文:病原性大腸菌の分類について. Medical Technology 14:166-167, 1986.

• 2) Su C, Brandt LJ:Escherichia coli O157:H7 infectioll in humans. Ann Int Med 123:698-714, 1995.
  pubmed

• 3) Kotloff K, et al:Shigella infection.In:Gastrointestinal Infections. Diagnosis and Management (JT Lamont, ed),pp265-291, Marcel Dekker,1997.

• 4) 相楽裕子:サルモネラ・エンテリティディス感染症. 臨床と微生物 25:173-178, 1998.
  Medical*Online

• 5) Mishu Allos B:Campylobacter. In Infectious Diseases (Gorbach SL, et al, eds), 2nd ed, WB Saunders, Philadelphia, 1998.

• 6) 坂本光夫ほか:エルシニア腸炎. 感染症症候群 (I). 日本臨牀 (別冊) pp493-495, 1999.

• 7) 飯田哲也:腸炎ビブリオ感染症. 毒素産性菌とその感染症 (竹田美文, 本田武司編), pp181-191, 1998.

• 8) Kelly CP, et al:Clostridiitm difficile infection. Ann Rev Med 49:375-390, 1998.
  pubmed

• 9) Kahn MY, et al:Staphylococcal enterocolitis treatment with oral vancomycin. Ann Intern Med 65:1-8, 1966.

• 10) 川嶋一成ほか:セレウス菌食中毒. 感染症症候群 (I). 日本臨牀 (別冊), pp463-469, 1999.

• 11) 桜井 純:ウェルシュ菌 (Clostridium Perfringens) 食中毒の正しい知識 改訂版 (三輪谷俊夫監修, 本田武司. 竹田美文編), pp70-74, 菜根出版, 1993.

• 12) Asaka M, et al:Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology 102:760-766, 1992.

• 13) 山川清孝:ボツリヌス菌 (Clostridium botulinum) 食中毒の正しい知識 改訂版 (三輪谷俊夫監修, 本田武司・竹田美文編) pp99-105, 菜根出版, 1993.

• 14) Kaplan SL:Pyogenic liver abscess. In Textbook of Pediatric Infectious Diseases (Feigin RD, Cherry JD, eds), 4th ed, pp655-658, WB Saunders, 1998.

第IV章 泌尿器細菌感染症

P.69 掲載の参考文献

• 1) 鈴木 仁ほか:細菌尿. 小児科診療 53:746-749, 1990.

• 2) 鈴木順造ほか:反復尿路感染症. 小児科 35:859-862, 1994.

• 3) 鈴木 仁ほか:尿路感染症. 小児科 36:717-721, 1995.

• 4) 鈴木 仁ほか:尿路感染症. 小児科診療 487-574, 2000.

第V章 神経系細菌感染症―細菌性髄膜炎―

P.88 掲載の参考文献

• 1) Roos KL, Tunkel AR, Scheld WM:Acute bacterial meningitis in children and adults in scheld WM:Infection of the central nervous system (Whitley RJ, Durak DT, ed), pp335-409, Raven Press, New York, 1991.

• 2) 橋本武夫:新生児化膿性髄膜炎. 周産期医学 6:175, 1976.

• 3) 玉置尚司, 福永 謙, 岡崎 実ほか:過去20年間に都内当科関連施設で経験した新生児化膿性髄膜炎の臨床的検討. 日児誌 97:97-106, 1993.

• 4) 特集 細菌性髄膜炎. 病原微生物検出情報.月報 国立感染症研究所. Vol16, pp176-177, 1995.

• 5) 藤井良知, 平岩幹男, 野中千鶴ほか:本邦における1979年以降6年間の小児細菌性髄膜炎の動向. 第1報 起炎菌について. 感染症学雑誌 60:592-600, 1986.

• 6) 福永 謙, 西村千英子, 玉置尚司ほか:過去20年間に経験した化膿性髄膜炎の検討.第1報 臨床と予後. 感染症学雑誌, 66:1042-1047, 1992.

• 7) 久保政勝:本邦臨床統計集 (上巻). 髄膜炎. 日本臨牀 50:94-100, 1992.

• 8) Morooka T:Epidemiologic application of pulsed-field gel electrophoresis to an outbreak of campylobacter fetus meningitis in a neonatal intensive care units. Scand J Infect Dis 28:269-270, 1996.

• 9) 高嶋幸男, 田中健蔵, 山下政美ほか:新生児化膿性髄膜炎の病理, とくに脳循環障害の病理学的考察. 脳と発達 2:430, 1970.

• 10) Plaut A. G:The IgA proteases of pathogenic bacteria. Annu Rev Microviol 37:603, 1983.
  pubmed

• 11) Quagliarello VJ, Sheld WM:New prospectives on bacterial meningitis. Clin Infect Dis 17:603-608, 1993.

• 12) Fearron DT:Regulation by membrane sialic acid of β 1H-dependent decay dissociation of amplication C3 convertase of the alternative complement pathway. Proc Natl. Acad Sci USA 75:1971-1975, 1978.

• 13) Brown EJ, Jponer KA, Gaither TA, et al:The interaction of C3b bound pneumococci with factor H (β1H globulin), factor I (C3b/C4b inactivator), and properdin factor B of the human complement system. J Immunol 131:409-419, 1983.

• 14) Townsend GC, Scheld WM.:Adjunctive therapy for bacterial meningitis:Rationale for use, current status, and prospects for future. Clin Infect Dis 17 (suppl 2); S537, 1993.

• 15) Quagliarello VJ, Sheld WM:Bacterial meningiti:pathogenesic, pathophysiology and pathogenesis. New Engl J Med 327:864-872, 1992.

• 16) Saez-Leorens X, Ramilio O, Mustafa MM, et al:Morecular pathophysiology of bacterial meningitis:Current concepts and therapeutic implications, J Pediatr 116:671-684, 1990.

• 17) 原 寿郎:免疫学からみた細菌性髄膜炎. 小児内科 31:75-79, 1999.

• 18) Herbert MA, Moxon ER:Meningitis:bacterial, viral, tuberculous, fungal, recurrent meningitis and parameningeal focus. In:apractical approach to pediatric infections (D. Moxon ER, ed), pp263-283, Churchill, Livingston, New York, 1996.

• 19) Mellor DH:The place of computed tomography and lumber puncture in suspected bacterial meningitis. Arch Dis Child 67:1417-1422, 1992.

• 20) Yogev R:Meningitis. In:pediatric infectious disease. Principles and practice (Jenson, HB, Baltimore RS, ed), pp781-807, Appleton Lange, New York, 1995.

• 21) Baily EM, Domenico P, Cunha BA:Bacterial or viral meningitis? Postgrad Med 88(5):217-219, 990.

• 22) 関 孝, 城 宏輔, 久保政勝:単球血管内皮細胞の活性化とネオプテリン. 第2報中枢神経炎症性疾患におけるH3髄液ネオプテリン. Jpn J Clin Immunol 15:232-238, 1992.

• 23) 中村 明:感染症-検体からの病因微生物の迅速同定, 化膿性髄膜炎. 小児科 33:1004-1007, 1992.

• 24) Snedeker JD, Kaplan SL, Dogze RR, et al:Subdural effusion and relationship with neurologic sequelae of bacterial meningitis in infancy. A prospective Study. Pediatircs 86:163-170, 1990.

• 25) Ashwal S, Perkin RM, Thompson JR, et al:Bacterial meningitis in children:Current concepts of neurologic management. Current Problems. Pediatr 24:267-284, 1994.

• 26) Snyder RD:Bacterial and spirochetal infections of the nervous system. In:Pediatric neurology (Swainlan KF ed,), pp611, Mosby. St. Louis, 1994.

• 27) Wald ER, Kaplan SL, Mason EO Jr, et al:Dexamethasone therapy for children with bacterial meningitis. Pediatr 95:21-31, 1995.

• 28) Prober CG:Infection of the central nervous system. In:Nelson Textbook of Pediatrics (Behrman RE, Kliegman RM, Aruin AM, ed), 15th ed, pp707-713, Saunders, Philadelphia, 1996.

• 29) Kato E:Administration of immune globulin associated with aseptic meningitis. JAMA 259:3269-3271, 1988.
  pubmed

• 30) Schlech WF III, Peltola H, Ruuskanen O, et al:Bacterial meningitis in the united states, 1978 through 1981:The National Bacterial meningitis Surveillance Study. JAMA 253:1749-1754, 1985.

• 31) Kaplan SL, Smith EO, Wills O, et al:Association between preadmission oral antibistic therapy and cerebrospinal fluid findings and sequelae caused by Haemophilus influenza type B menignitis. Pediatr Infect Dis 5:625-632, 1987.

• 32) 藤井良知, 平岩幹夫, 小林 裕:本邦における1979年以降6年間の小児細菌性髄膜炎の動向. 第3報 抗生剤の単独又は併用療法と予後について. Jap J Antibiotics 37:284-294, 1987.

• 33) 春田恒和:神経系感染症. 小児の化学療法 (藤井良知, 西村 史, 砂川慶介編), pp240-246, 金原出版, 東京, 1991.

• 34) 春田恒和:化膿性髄膜炎の治療. 小児内科 28:900-905, 1996.

• 35) Appelbaum DC:Streptococcus pneumonia resistant to penicillin and chloramphemical. Lancet ii:995-997, 1977.

• 36) 生方公子:我が国におけるペニシリン耐性肺炎球菌の疫学とその耐性機構. 小児感染免疫 10:131-137, 1998.

• 37) 岩田 敏:ペニシリン耐性肺炎球菌-臨床の立場から-. 小児感染免疫 10:139-146, 1998.

• 38) 藤枝憲二:低浸透圧症候群. 小児科学 (白木和夫, 前川喜平編), p 1293, 医学書院, 東京, 1997.

• 39) Lebel MH, Hoyt J, Waagner DC, et al:Magnetic resonance imaging and dexamethasone therapy for bacterial meningitis. Am J Dis Child 143:301-306, 1989.

• 40) Mclntyre PB, Berky CS, King SM, et al:Dexamethasone as adjunctive therapy inbacterial meningitis. JAMA 278:925-931, 1997.

• 41) Meningococcal disease surveilance group:Analysis of endemic meningococcal disease by serogroup and evaluation of chemoprophylaxis. J Infect Dis 134:201-204, 1976.

• 42) Olcen P:Epidemiology of Neisseria meningitidis prevalance and symptoms from the upper respiratory tract in family members to patients with meningococcal disease. Scand J Infect Dis 13:105-109, 1981.

• 43) Chez M, Sila CA, Ransohoff RM, et al:Ibuprofen-induced meningitis, Detection of intrathecal IgG synthesis and immune complexe. Neurology 39:1578-1580, 1989.

• 44) 藤井良知, 平岩幹夫, 小林 裕:本邦における 1979年以降6年間の小児細菌性髄膜炎の動向. 第2報 予後について. 感染症学雑誌 61:849-857, 1987.

• 45) 山下直哉, 浅村信二, 小佐野 満:生後1か月以後の小児細菌性髄膜炎II. 予後に関連する因子の検討. 日児誌 92:2540-2546, 1988.

• 46) 佐藤 保:ADH 分泌不適切症候群の病態と治療. 小児内科 31:1148-1150, 1999.

第VI章 伝染性膿痂疹

P.102 掲載の参考文献

• 1) Fitzpatrick TB, et al:Dermatology in general medicine, 4th ed, p 2324, McGraw Hill, 1993.

• 2) Todd J, Fishaut M:Toxic shock associated with phage-group-I staphylococci, Lancet 2, p 1116, 1978

第VII章 骨関節感染症

P.111 掲載の参考文献

• 1) Dubey L, Krasinski K, Hernanz-Schulman M:Osteomyelitis secondary to trauma or infected contiguous soft tissue. Pediatr Infect Dis J 7:26-34, 1988.
  pubmed

• 2) Lew DP, Waldvogel FA:Osteomyelitis. N Engl J Med 336:999-1007, 1997.
  pubmed

• 3) Goldenberg DL:Septic arthritis. Lancet 351:197-202, 1998.
  pubmed

• 4) Dagan R:Management of acute hematogenous osteomyelitis and septic arthritis in the pediatric patient. Pediatr Infect Dis J 12:88-92, 1993.
  pubmed

• 5) Wong M, Isaacs D, Howman-Giles R, et al:Clinical and diagnostic features of osteomyelitis occurring in the first three months of life. Pediatr Infect Dis J 14:1047-1053, 1995.
  pubmed

• 6) Roine I, Faingezicht I, Arguedas A, et al:Serial serum C-reactive protein to monitor recovery from acute hematogenous osteomaelitis in children. Pedaitr Infect Dis J 14:40-44, 1995.

• 7) Peltola H, Unkila-Kallio L, Kallio MJT, et al:Simplified treatment of acute staphylococcal osteomyelitis of childhood. Pediatrics 99:846-850, 1997.

• 8) Gold R:Q & A; Radiographic diagnosis of osteomyelitis. Pediatr Infect Dis J 14:555, 1995.

• 9) Fitzpatrick DJ, Cafferkey MT, Toner M, et al:Osteomyelitis with methicillin-resistant Staphylococcus aureus. J Hosp Infect 8:24-30, 1986.
  pubmed

• 10) Bradley JS, Kaplan SL, Tan TQ, et al:Pediatric penumococcal bone and joint infections. Pediatrics 102:1376-1382, 1998.

• 11) Prober CG:Oral antibiotic therapy for bone and joint infections. Pediatr Infect Dis 1:8-10, 1982.
  pubmed

• 12) Syrogiannopoulos GA, Nelson JD:Duration of antimicrobial therapy for acute suppurative osteoarticular infections. Lancet i:37-40, 1988.
  pubmed

• 13) Glover SC, McKendrick MW, Padfield C, et al:Acute osteomyelitis in a district general hospital. Lancet i:609-611, 1982.

• 14) Fink CW, Nelson JD:Septic arthritis and osteomyelitis in children. Clin Rheum Dis 12:423-435, 1986.
  pubmed

第VIII章 伝染性疾患

P.128 掲載の参考文献

• 1) Kaplan EL:Group A Streptococcal infections. Textbook of pediatric infectious diseases (Feigin RD, ed), 3rd ed, p 1269, Saunders, Philadelphia, 1992.

• 2) Todd J:Streptococcal infections. Nelson textbook of pediatric (Behrman RE, et al, ed), 15th ed, p 750, WB Saunders, Philadelphia, 1996.

• 3) Bisno AL:Streptococcus pyogenes. Principles and practice of infectious diseases (Mandell GL, ed), 4th ed, Churchill Livingstone, New York, 1995.

• 4) 清水可方:劇症型A群溶レン菌感染症の臨床. 小児科臨床 48:2495, 1995.

• 5) 藤川 敏ほか:Anti-deoxyribonuclease B (ADNase B) 測定の臨床的意義と他のレンサ球菌抗体との相関について. リウマチ 20:11, 1980.

• 6) 宮崎博:リウマチ熱および小児溶レン菌関連疾患の各種溶レン菌抗体に関する研究. 医学研究 55:200, 1985.

• 7) Pichichero ME:Cephalosporins are superior to penicillin for treatment of streptococcal tonsillopharyngitis:is the difference worth it? Pediatr Infect Dis J 12:268, 1993.
  pubmed

• 8) Feigin RD, Cherry JD:pertussis. Textbook of pediatric infectious diseases (Feigin RD, ed), 3rd ed, p 1208, Saunders, Philadelphia, 1992.

• 9) Todd J:Streptococcal infections. Nelson textbook of pediatrics (Behrman RE, et al, ed), 15th ed, p 779, WB Saunders, Philadelphia, 1996.

• 10) 黒崎知道:小児の検査結果の考え方. 小児内科 30 (増刊):458, 1998.

• 11) 青山辰夫:百日咳・パラ百日咳:小児科診療 58 (増刊):144, 1995.

• 12) Feigin RD, Strechenberg BW, Strandgaard Bo H:pertussis. Textbook of pediatric infectious diseases (Feigin RD, ed), 3rd ed, p 1110, Saunders, Philadelphia, 1992.

• 13) Long SS:Diphtheria. Nelson textbook of pediatrics (Behrman RE, et al, ed), 15th ed, p 775, WB Saunders, Philadelphia, 1996.

• 14) Centers for Disease Control (CDC):Diphtheria epidemic-New independent stages of the former Soviet Union, 1990-1994. MMWR 44:177, 1995.

• 15) Weinstein L:Tetanus. Textbook of pediatric infectious diseases (Feigin RD, ed), 3rd ed, p 1102 Saunders, Philadelphia, 1992.

• 16) Arnon SS:Tetanus. Nelson textbook of pediatrics (Behrman RE, et al, ed), 15th ed, p 815, W Saunders, Philadelphia, 1996.

• 17) Report of the committee on infectious diseases (1994 Red Books), 23th ed, p 458. Tetanus (Lockjaw), 1994.

第IX章 慢性感染症

P.131 掲載の参考文献

• 1) 厚生省保健医療局結核感染症課監修:結核の統計 1998. 財団法人結核予防会, 東京, 1998.

• 2) 高松 勇, 亀田 誠, 井上寿茂ほか:小児結核の現状と今後の課題. 結核 70:57-65, 1995.

• 3) 高松 勇, 豊島協一郎:小児結核. 資料と展望 8:24-37, 1994.

• 4) 高松 勇:小児結核に思う. 保健婦の結核展望 34:36-37, 1996.

• 5) Rouillon A, et al:Transmission of tubercle bacilli:The effects of chemotherapy. Tubercle 57:275-299, 1976.
  pubmed

• 6) Sepkowitz KA:How contagious is tuberculos is? Clinical Inf Diseases 23:954-962, 1996.

• 7) 青木正和:結核集団感染. 結核管理技術シリーズ-2, 結核予防会発行, 1988.

• 8) Grzybowski S, et al:Contacts of cases of active pulmonary tuberculosis. Bull IUAT 50:90-106, 1975.

• 9) Margaret HD:Tuberculosis and Other Mycobacterial Infection, Ralph DF:Text-book of Pediatric Infectious Diseases, pp1016-1060, Saunders, 1981.

• 10) Pierre C, et al:Diagnosis of Primary Tuberculosis in Children by Amprification and Detection of Mycobacterial DNA. Am Rev Respir Dis 147:420-424, 1993.
  pubmed

• 11) Lassence A, et al:Detection of mycobacterial DNA in pleural fluid from patients with tuberculous pleurisy by means of the polymerase chain reaction:comparison of two protocols. Thorax 47:265-269, 1992.
  pubmed

• 12) Smith PG:Case-control studies of the efficacy of BCG against tuberculosis. xxv th IUAT World Conf, pp73-79, 1986.

• 13) Colditz GA, et al:Efficacy of BCG Vaccine in the Prevention of Tuberculosis. JAMA 271:698-702, 1994.
  pubmed

• 14) Scientific Comittees of the IUATLD:Guideline for diagnosis, prevention and treatment:Tuberculosis in children. Bull Int Union Tuberc Lung Dis 66:61-67, 1991.

• 15) WHO:Guideline for the treatment in adults and children in national tuberculosis programes. P 161, WHO/Tub, 1991.

• 16) Committee on Infectious Diseases:Chemotherapy for tuberculosis in infants and children. Pediatrics 89 (1):161-165, 1992.
  pubmed

• 17) J Starke, et al:Management of mycobacterial infection and disease in children. Pediatr Infec Dis J 14:455-470, 1995.

• 18) 厚生省保健医療局エイズ結核感染症課監修:新しい結核医療の基準の概略. 結核医療の基準とその解説. 結核予防会発行, 1996.

• 19) 高松 勇, 村山史秀, 土井 悟ほか:PZAを加えた小児肺結核6ヵ月治療成績. 日本小児呼吸器疾患雑誌 5:102-105, 1995.

• 20) 豊島協一郎:小児結核の短期化学療法. 日本小児呼吸器疾患雑誌 5:47-50, 1994.

• 21) 青木正和:結核化学療法による肝障害 (review). 資料と展望 23:1-12, 1997.

• 22) 高松 勇:第73回総会教育講演. 小児結核の現状と治療. 結核 (印刷中).

• 23) 厚生省保健医療局結核・感染症対策室監修:命令入所及び初感染結核通知. 命令入所 及び初感染結核の取扱いとその解説. 結核予防会発行, 1989.

• 24) O'Brien RJ:Preventive therapy for tuberculosis. In:Clinical Tuberculosis ed by PDO Davies, Chapman and Hall Medical, pp279-295, London, 1994.

• 25) CDC:Prevention and treatment of Tuberculosis Among Patients Infected with Human Immunodeficiency Virus:Principles of Therapy and Revised Recommendation. MMWR Oct 30, Vol 47/No RR-20, 1998.

P.141 掲載の参考文献

• 1) 日本結核病学会非定型抗酸菌症対策委員会:非定型抗酸菌症の治療に関する見解. 結核 73(10):599-605, 1998.

• 2) Frucht DM, Holland SM:Defective monocyte costimulation for IFN-gamma production in familial disseminated Mycobacterium avium complex infection:abnormal IL-12 regulation. J Immunol 157:411-416, 1996.
  pubmed

• 3) 島津和孝, 中川義久, 蛯原桃子ほか:非定型抗酸菌症患者の背景因子に関する臨床的 検討-発症素因と環境について-. 結核 73:287-293, 1998.

• 4) 植田浩司, 岡田賢司, 日高靖文:小児の非定型抗酸菌症 (非結核性抗酸菌症). 感染症 26(4):157-161, 1996.

• 5) Lincoln E, Gilbert LA:Disease in children due to mycobacteria other than Mycobacterium tuberculosis. Amer Rev Respir Dis 105:683-714, 1972.

• 6) 片岡直樹, 稲葉 淳, 涌波淳子ほか:非定型抗酸菌性頸部リンパ節炎の3小児例と文献的考察. 日児誌 99:556-563, 1995.

• 7) 堤 寛:非定型抗酸菌症. 病理と臨床 15:60-61, 1997.
  Medical*Online

• 8) 雉本忠市, 初鹿野浩, 小原 洋ほか:軽快せしめえた小児の限局性非定型抗酸菌症の2症例. 結核 57:222, 1982 (学会抄録).

• 9) Borghans JG, Stanford JL:Mycobacterium chelonei in abscesses after infection of diphteria-pertussis-tetanus-polio vaccine. Am Rev Respir Dis 107:1-8, 1973.
  pubmed

• 10) 加我牧子, 茂木富美子, 坂本 博ほか:肺嚢胞症に合併した Mycobacterium intracellulare症の1例. 小児科臨床 30:277-279, 1977.
  Medical*Online

• 11) 松島正視:非定型抗酸菌症. 小児科診療 46:1852-1858, 1983.

• 12) Joshi W, Davidson PM, Jones PG, et al:Non-tuberculous mycobacterial lymphoadenitis in children. Eur J Pediatr 148:751-754, 1989.

• 13) 坂谷光則:非定型抗酸菌症. 実験治療 646:86-88, 1997.

• 14) Preheim RC, Smith TL:Mycobacterial infections:new threats from old diseases. Comprehensive Therapy 23:310-318, 1997.

• 15) Arnold JH, Scott AV, Spitznagel JK:Specificity of PPD skin tests in childhood tuberculin converters:Comparison with mycobacterial species from tissues and secretions. J Pediatr 76:512-522, 1970.
  pubmed

• 16) 重藤えり子, 田坂博信:健康者有志における非定型抗酸菌ツベルクリン-PPD-B, PPD-Y, PPD-F. 結核 68:283-291, 1993.

• 17) 重藤えり子, 田坂博信ほか:(非定型抗酸菌症研究協議会共同研究):抗酸菌症患者に おける非定型抗酸菌ツベルクリン反応-PPD-S, PPD-B, PPD-Y, PPD-F, PPD-C の検討-. 結核 68:351-360, 1993.

• 18) 原田泰子, 原田 進, 加治木章ほか:Mycobacterium avium complex症における PPD:Bによるツベルクリン反応の診断的有用性に関する検討. 結核 73:349-353, 1998.

• 19) 倉島篤行, 毛利昌史:非定型抗酸菌症の新しい治療. 日胸 54 (suppl 11):S 164-170, 1995.

• 20) 厚生省保健医療局エイズ結核感染症課:結核活動性分類の解説. (財) 結核予防会, 1996. 3.

第X章 特殊病態下での細菌感染症

P.151 掲載の参考文献

• 1) Van der Waaij D, Berghuis JM, Lekkerkerk JEC:Colonization resistance of the digestive tract of mice during systemic antibiotic treatment. J Hyg 70:605-610, 1972.

• 2) 吉岡 一ほか:免疫機能低下患児の敗血症と腸内細菌-colonization resistanceの臨床的意義-. 小児科 30:811-816, 1989.

• 3) 神谷 齊, 荒井祥二朗, 中野貴司:免疫不全の感染症-敗血症を中心に-. 小児科臨床 45:1026-1030, 1992.
  Medical*Online

• 4) Hughes WT, Armstrong D, Bodey GP, et al:Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J infect Dis 161:381-396, 1990.
  pubmed

• 5) 小児白血病研究会(JACLS):ALL-97治療研究;感染症の予防と治療&抗生剤, pp51-55, 1997年4月.

• 6) Schimppff SC:Origin of infection in acute nonlymphocytic leukemia. Ann Intern Med 77:707-714, 1972.

• 7) 神谷 齊, 荒井祥二朗:Compromised hostと細菌感染症-予防と治療-. 小児科診療 54:1323-1330, 1991.

• 8) 矢島周平, 本郷輝明:小児白血病治療中の感染とその対策. 小児内科 29:269-277, 1997.

• 9) Nauseff WM, Maki DG:A study of the value of simple protective isolation in patients with granulocytopenia. N Engl J Med 304:448-453, 1981.

• 10) Storring RA, Jameson B, McElwain TJ, et al:Oral non-absorbed antibiotics prevent infection in acute non-1ymphoblastic leukemia. Lancet 2:837-840, 1977.
  pubmed

• 11) 堂園晴彦, 中村和男, 本屋敏郎ほか:癌化学療法時にみられる口内炎の予防. 癌と化学療法 16:3449-3451, 1989.
  Medical*Online

• 12) 寺田明彦, 早川豪俊, 駒田幹彦ほか:感染性心内膜炎を合併したアトピー性皮膚炎の1男児例. 日本小児科学会雑誌 103:853-856, 1999.

P.161 掲載の参考文献

• 1) Gotoff SP:Infection of the Neonate:Section 1 Unique aspect of infection. In:NelsonTextbook of Pediatrics (15th Ed.), Saunders, 1996.

• 2) Stoll BJ, Gordon I, Korones SB, et al:Late-onset sepsis in very low birth weight neonates:A report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 129:63-71, 1996.

• 3) Quie P:Antimicrobial defences in the neonate. Semin Perinatol 14:2-9, 1990.
  pubmed

• 4) Yoder M, Polin R:Immunotherapy of neonatal septicemia. Pediatr Clin North Am 33:481-501, 1986.
  pubmed

• 5) Wilson C:Immunologic basis for increased susceptibility of the neonate to infection. J Pediatr 108:1-12, 1986.
  pubmed

• 6) Edwards M:Complement in neonatal infections:An overview. Pediatr Infect Dis J 5:168-170, 1986.

• 7) Centers for Disease Control and Prevention. Prevention of perinatal group B strep diseases:A public health perspective. MMWR 45 (RR7), 1996.

• 8) Boyer KM, Gadzala CA, Kelly PD, et al:Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. II. Predictive value of prenatal cultures. J Infect Dis 148:802-809, 1983.

• 9) Boyer KM, Gadzala CA, Burd LI, et al:Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. I. Epidemiologic rationale. J Infect Dis 148:795-801, 1983.

• 10) Gerdes JR:Clinicopathologic approach to the diagnosis of neonatal sepsis. Clin Perinatol 7:122-126, 1987.

• 11) Dietzman DE, Fischer GW, Shoenkneckt FD:Neonatal Escherichia coli septicemiabacterial counts in blood. J Pediatr 85:128-130, 1974.

• 12) Neal PR, Kleiman MB, Reynolds JK, et al:Volume of blood submitted for culture from neonates. J Clin Microbiol 24:353-356, 1986.
  pubmed

• 13) Schelonka RL, Chai MK, Yoder BA, et al:Volume of blood required to detect common neonatal pathogens. J Pediatr 129:275-278, 1996.
  pubmed

• 14) Fisher GW, Crumrine MH, Jenning PB:Experimental Escherichia coli sepsis in rabbits. J Pediatr 85:117-119, 1974.

• 15) Manroe BL, Weinberg AG, Weinberg AG, et al:The differential leukocyte count in the assessment and outcome of early-onset neonatal group B streptococcal disease. J Pediatr 91:632-637, 1977.

• 16) Manroe BL, Weinberg AG, Weinberg AG, et al:The neonatal blood count in health and disease. I. Reference values for neutrophilic cells. J Pediatr 95:89-98, 1979.

• 17) Zuerlein TJ, O'Connor TA, Kilbride HW, et al:Use of standard neutrophilic references values for prediction of sepsis in ≦800 gram birthweight infants. J Matern Fetal Med 3:166-170, 1994.

• 18) Mouzinho A, Rosenfeld CR, Sanchez PJ, et al:Revised reference ranges for circulating neutrophils in very low birhtweight neonates. Pediatrics 94:76-82, 1994.

• 19) Benuck I, David RJ:Sensitivity of published neutrophi indexes in identifying newborn infants with sepsis. J Pediatr 103:961-963, 1983.

• 20) Squire E, Favara B, Todd J:Diagnosis of neonatal bacterial infection:Hematologic and pathologic findings in fatal and nonfatal cases. Pediatrics 64:60-64, 1979.
  pubmed

• 21) Engle WD, Rosenfeld CR, Mouzinho A, et al:Circulating neutrophils in septic preterm neonates:Comparison of two reference rages. Pediatrics 99:1-6, 1997.

• 22) Messer J, Eyer D, Donato L, et al:Evaluation of interleukin-6 and soluble receptors of tumor necrosis factor for early diagnosis of neonatal infection J Pediatr 129:574-580, 1996.
  pubmed

• 23) Lehrnbecher T, Schrod L, Kraus D, et al:Interleukin-6 and soluble interleukin-6 receptor in cord blood in the diagnosis of early onset sepsis in neonates. Act Paediatr 84:806-808, 1995.

• 24) Gerdes JS, Polin RA:Sepsis screen ln neaonates with evaluation of plasma fibronectin. Pediatr Infect Dis J 6:443-446, 1987.

• 25) Philip AG, Hewitt JR:Early diagnosis of neonatal sepsis. Pediatrics 65:1036-1041, 1980.
  pubmed

• 26) Doellner H, Arntzen KJ, Haeried PE, et al:Interleukin-6 concentrations in neonates evaluated for sepsis. J pediatr 132:295-299, 1998

• 27) Gendrel D, Assicot M, Raymond J, et al:Procalcitonin as a marker for the early diagnosis of neonatal infection. J Pediatr 128:570-573, 1996
  pubmed

• 28) Spear ML, Stefano JL, Fawcett P, et al:Soluble interleukin-2 as a predictor of neonatal sepsis. J pediatr 126:982-985, 1995
  pubmed

• 29) Guerina NG:Bacterial and fungal infections. In:Manual of Neonatal Care, 4th ed, Lippincott-Raven, 1998.

第XI章 細菌感染症を引き金とする免疫異常反応とその対策

P.179 掲載の参考文献

• 1) Waage A, Halstensen A, Espevik T:Association between tumor necrosis factor in serum and fatal outcome in patients with meningococal meningitis. Lancet 1:355-357, 1987.

• 2) Members of the American college of chest physician/society of critical care medicine consensus conference committee. American college of chest physicians/society of critical care medicine consensus conference:Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864-874, 1992.

• 3) The ACCP/SCCM consensus conference committee:Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101:1644-1655, 1992
  pubmed

• 4) Bone RC, Grodzin CJ, Balk RA:Sepsis:a new hypothesis for pathogenesis of the disease process. Chest 112:235-243, 1997.
  pubmed

• 5) Davis M, Hagen PO:Systemic inflammatory response syndrome. Br J Surgery 84:920-925, 1997.

• 6) Anderson MR, Blumer JL:Advances in the therapy for sepsis in children. Pediatr Clin North Am 44:179-205, 1997.
  pubmed

• 7) Rangel-Frausto MS, Pittet D, Costigan M, et al:The natural history of the systemic inflammatory response syndrome (SIRS) . JAMA 273:117-123, 1995.
  pubmed

• 8) Pittet D, Rangel-Frausto S, Li N, et al:Systemic inflammatory response syndrome, sepsis, severe sepsis and septic shock:Incidence, morbidites and outcomes in surgical ICU patients. Intensive Care Med 21:302, 1995.

• 9) Bone RC:Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 24:1125-1128, 1996.

• 10) Ziegler-Heitbrock HWL:Heterogeneity of human blood monocytes:The CD14+ CD16+ subpopulation. Immunol Today 17:424-428, 1996.

• 11) Fingerle G, Pforte A, Passlick B, et al:The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients. Blood 82:3170-3176, 1993.
  pubmed

• 12) Kox WJ, Bone RC, Krausch D:Interferon gamma-1b in the treatment of compensatory anti-inflammatory response syndrome. Arch Intern Med 157:389-393, 1997.
  pubmed

• 13) Tracey KJ, Beutler B, Lowry SF, et al:Shock and tissue injury induced by recombinant human cachectin. Science 234:470-474, 1986.
  pubmed

• 14) Brouckaert P, Fiers W:Tumor necrosis factor and the systemic inflammatory response syndrome. Curr Top Microbiol Immunol 216:167-187, 1996.
  pubmed

• 15) Dinarello CA:Interleukin-1. Reviews of infectious diseases 6:51-95, 1984.
  pubmed

• 16) Wagge A, Brandtzawg P, Halstensen A, et al:The complex pattern of cytokines in serum with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med 169:333-338, 1989.

• 17) Bossink AW, Paemen L, Jansen PM, et al:Plasma levels of the chemokines monocyte chemotactic proteins-1 and-2 are elevated in human sepsis. Blood 86:3841-3847, 1995.
  pubmed

• 18) Fujishima S, Sasaki J, Shinozawa Y, et al:Serum MIP-1αand IL-8 in septic patients. Intensive Care Med 22:1169-1175, 1996.

• 19) Pretolani M, Goldman M:IL-10:a potential therapy for allergic inflammation ? Immunol Today 18:277-280, 1997.
  pubmed

• 20) Kasai T, Inada K, Takakuwa T, et al:Anti-inflammatory cytokine levels in patients with septic. Res Commun Mol Pathol Pharmacol 98:34-42, 1997.
  pubmed

• 21) Pilz G, Fraunberger P, Appel R, et al:Early prediction of outcome in score-identified, postcardiac surgical patients at high risk for sepsis, using soluble tumor necrosis factor receptor-p55 concentrations. Crit Care Med 24:596-600, 1996.
  pubmed

• 22) Adams DH, Shaw S:Leukocyte-endothelial interactions and regulation of leukocyte migration. Lancet 343:831-836, 1994.
  pubmed

• 23) Boldt J, Muller M, Kuhn D, et al:Circulating adhesion molecules in the critically ill:a comparison between trauma and sepsis patients. Intensive Care Med 22:122-128, 1996.
  pubmed

• 24) Fujishima S, Aikawa N:Neutrophil-mediated tissue injury and its modulation. Intensive Care Med 21:277-285, 1995.
  pubmed

• 25) Tsukahara Y, Morisaki T, Horita Y, et al:Expression of inducible nitric oxide synthase in circulating neutrophils of the systemic inflammatory response syndrome and septic patients. World J Surg 22:771-777, 1998.
  pubmed

• 26) Abraham E, Anzueto A, Gutierrez G, et al:Double-blind randomised controlled trial of monoclonal antibody to human tumor necrosis factor in treatment of septic shock. Lancet 351:929-933, 1998
  pubmed

• 27) Abraham E, Glauser MP, Butler T, et al:p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study Group. JAMA 277:1531-1538, 1997.

• 28) Fisher CJ, Dhainaut JD, Opal SM, et al:Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. JAMA 271:1836-1843, 1994.

• 29) Remick DG, Garg SJ, Newcomb DE, et al:Exogenous interleukin-10 fails to decrease the mortality of morbidity of sepsis. Crit Care Med 26:895-904, 1998.
  pubmed

• 30) Zeni F, Pain P, Vindimian M, et al:Effects of pentoxifylline on circulating cytokine concentrations and hemodynamics in patients with septic shock:Results from a double-blind, randomized, placebo-controlled study. Crit Care Med 24:207-214, 1996.
  pubmed

• 31) Scheinman RI, Cogswell PC, Lofquist AK, et al:Role of transcriptional activation of I kappa B alpha in mediation of immunosupression by glucocorticoids. Science 270:283-286, 1995.

• 32) 標葉隆三郎:SteroidによるSIRSの制御. 集中治療 10:849-854, 1998.

• 33) 青笹季文, 小野 聡, 辻本広紀ほか:Protease inhibitorによるSIRSの制御. 集中治療 10:855-862, 1998.

• 34) Murakami K, Okajima K, Uchiba M, et al:Gabexate mesilate, a synthetic protease inhibitor, attenuates endotoxin-induced pulmonary vascular injury by inhibiting tumor necrosis factor production by monocytes. Crit Care Med 24:1047-1053, 1996.
  pubmed

• 35) 松田兼一, 平澤博之, 志賀英敏:CHDFによるSIRSの制御. 集中治療 10:863-872, 1998.

• 36) 古川 漸:スーパーアンチゲン. 小児感染免疫 5:71-78, 1993.

• 37) 内山竹彦:細菌性スーパー抗原 (永井美之, 渡邊治男編), 実験医学別冊ウイルス・細菌感染newファイル, pp117-119, 羊土社, 1997.

• 38) Uchiyama T, Yan XJ, Imanishi K, et al:Bacterial superantigens-mechanism of T cell activation by the superantigens and their role in the pathogenesis of infectious diseases. Microbiol Immunol 38:245-256, 1994.
  pubmed

• 39) Schiffenbauer J, Soos J, Johnson H:The possible role of bacterial superantigens in the pathogenesis of autoimmune disorders. Immunol Today 19:117-120, 1998.

• 40) Abe J, Kotzin BL, Jujo K, et al:Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease. Proc Natl Acad Sci USA 89:4066-4070, 1992.
  pubmed

• 41) Leung DY, Meissner HC, Fulton DR, et al:Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet 342:1385-1388, 1993.
  pubmed

• 42) Yoshioka T, Matsutani T, Toyosaki-Maeda T, et al:Polyclonal expansion of TCRBV2-and TCRBV6-bearing T cells in patients with Kawasaki disease. Immunology 96:465-472, 1999.
  pubmed

• 43) Terai M, Miwa K, Williams T, et al:The absence of evidence of staphylococcal toxin involvement in the pathogenesis of Kawasaki disease. J Infect Dis 172:558-561, 1995.
  pubmed

• 44) Pietra BA, De Imcencio J, Giannini EH, et al:TCR V beta family repertoire and Tcell activation markers in Kawasaki disease. J Immunol 153:1881-1888, 1994.

• 45) Matsubara T, Katayama K, Matsuoka T, et al:Decreased interferon-gammaproducing T cells in patients with acute Kawasaki disease. Clin Exp Immunol 116:554-557, 1999.

第XII章 細菌感染症の防御対策と効果的な殺菌法と消毒法の実際

P.202 掲載の参考文献

• 1) 「感染症の予防及び感染症の患者に対する医療に関する法律」. 平成10.10.2法律114.

• 2) 「感染症の予防及び感染症の患者に対する医療に関する法律及び検疫法及び狂犬病予防法の一部を改正する法律について」.(依命通知) 平成10.10.20厚生省発健医346・10番 畜 A 2227.

• 3) 特集 感染症新法施行に向けて-実地医家はどう対応するか-Medical Tribune Infection control 1999年3月11日.

• 4) 梅田 勝:新興・再興感染症と感染症新法制定. 小児内科37:5-11, 1999.

• 5) 松原 肇, 朝長文弥:消毒薬の種類と特性. 小児内科26:14-18, 1994.

• 6) 波多江新平, 宇部川弘行:4. 消毒の実際 院内感染予防対策ハンドブック-インフェクションコントロールの実際-(国立大阪病院感染対策委員会編), pp21-30, 南山 堂, 東京, 1998.

• 7) 田島 剛:効果的な消毒法の実際. 小児内科31:47-49, 1999.

• 8) Hospital Infection Control Practices Advisory Committee Guidelines for Isolation precoutious in Hospitals. Infect Control Hosp Epidemiol. 17:53-80, 1996. (erratum correction, Infect Control Hosp Epidemiol 17:214, 1996.)

• 9) 「病院における隔離予防策のためのCDC最新ガイドライン」Infection Control別冊, メディカ出版, 大阪, 1996.

• 10) Centers for Disease Control. Recommendations for prevention of HIV transmision in health-care settings. MMWR 36 (2S):1S-18S, 1987.

• 11) Centers for Disease Control. Update:universal precautious for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health carre settings. MMWR 37:377-382, 387-388, 1988.

• 12) Lynch P, Jackson MM, Cummings MJ, et al:Rethinking the role of isolation practices in the prevention of nosocomial infections. Ann Intern Med 107:243-246, 1987.
  pubmed

• 13) Lynch P, Cummings MJ, Roberts PL, et al:Implementing and evaluating a system of generic infection precautions:body substance isolation. Am J Infect Control 18:1-12, 1990.
  pubmed

• 14) Talban OC, Anderson LJ, Arden NH, et al:Hospital Infection Control Practice Advisory Committee. Guideline for prevention of nosocomial pneumonia Part I:issues on prevention of nosocomial pneumonia. Am J Infect Control 12:1191-1209, 1994.

• 15) Hospital Infection Control Practice Advisory Committee. Guideline for prevention of nosocomial pneumonia Part II:recommendations for prevention of nosocomial pneumonia. Am J Infect Control 22:269-292, 1994, and Americal Association of Respiratory Care 12:1209-1236, 1994.

• 16) Centers for Disease Control. Guidelines for preventing the transmission of tuberculosis in health-care facilities, 1994. MMWR 43 (RR-13):1-132, 1994, and Federal Resister 59:54242-54303, 1994.

• 17) Department of Health and Human Service, Department of Labor. Respiratory protective devices:final rules and notice. Federal Register 60:30336-30402, 1995.

• 18) Larson RL 1992, 1993, and 1994 Association for Professionals in Infection Control and Epidemiology Guidelines Committee. APIC guideline for handwashing and hand antiseptis in health care settings. Am J Infect control 23:251-269, 1995.

• 19) Hospital Infection Control Practice Advisory Committee. Recommendations for preventingthe spread of vancomycin resistance. Am J Infect Control 23:87-94, 1995, Infect Control Hosp Epidemiol 16:105-113, 1995, and MMWR 44 (No. RR-12):1-131995.

• 20) 小塚雄民, 山田泰子:1. 院内感染対策の進め方, 院内感染予防対策ハンドブック -インフェクションコントロールの実際-(国立大阪病院感染対策委員会編), pp2-8, 南山堂, 東京, 1998.

• 21) 加藤達男:日本で許可されているワクチンと接種方法. Modern Physician 17:277-280, 1997.

• 22) 子どものための予防接種-各国の状況-1997年度. (財)母子衛生研究会.

• 23) 「初感染結核に対するINHの投与について」. 平成元年2月28日付 健医発第20号 厚生省保健局結核・感染対策室長通知.

• 24) 青木泰子:院内感染症 (日和見感染). 臨床検査 42:1439-1452, 1999.

• 25) 賀来満夫:2. 院内感染症の原因微生物, 院内感染予防対策ハンドブック-インフェクションコントロールの実際- (国立大阪病院感染対策委員会編), pp9-15, 南山堂, 東京, 1998.

• 26) Center for Disease Control and Prevention:Nosocomial enterococci resistant to vamcomycin United State 1983-1993. MMWR 42:597-599, 1993.

• 27) Kliebe C, et al:Evaluation of plasmid-coded resistance to broad spectrum cephalosporins. Antimicrob Agents Chemother 28:302-307, 1985.

• 28) 岡 慎一:偽膜性大腸炎患者腸管内におけるclostridium difficileの動態と環境汚染について. 感染症誌 62:685-693, 1988.

• 29) 厚生省保健医療局結核.感染症対策室長通知. 初感染症結核に対するINHの投与について. 健医感第20号, 平成元年2月28日.

第XIII章 抗菌剤の使い方―選択から使用まで―

P.235 掲載の参考文献

• 1) 豊永義清:小児科領域感染症に対する抗菌薬の使い方. 上田 泰, 松本文夫, 柴孝也編. 臨床医のための抗微生物化学療法, pp177-183, ライフサイエンス, 1998.

• 2) 豊永義清:肺炎(1)小児の場合. 永武 毅編. 感染症診断臨床ガイド, pp43-56, 医薬ジャーナル社, 1999.

• 3) 豊永義清:各科領域におけるPRSP感染症の治療 3) 小児科領域, a) 上気道炎, 副島林造編.肺炎球菌感染症ハンドブック, pp86-99, 医薬ジャーナル社, 1997.

• 4) 豊永義清:薬物動態の面から. 小児科臨床 42:226-240, 1989.

• 5) 田中 誠:三浦真治, 山崎美喜雄ほか:小児細菌性上気道感染症におけるペニシリン耐性肺炎球菌の検出率及び各種経口薬剤の抗菌力について (第2報). 山梨医学27:151-158, 1999.

• 6) 藤井良和:β-ラクタム剤の詳細と選択. 藤井良和, 西村忠史, 砂川慶介編. 小児の化学療法, pp109-122, 金原出版, 1991.